Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Bio (NQ: CBIO )

5.690 USD -0.200 (-3.40%)
Official Closing Price Updated: 4:24 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 437,100
Open 6.000
Bid (Size) 5.610 (1)
Ask (Size) 5.970 (2)
Prev. Close 5.890
Today's Range 5.370 - 6.020
52wk Range 3.430 - 8.220
Shares Outstanding 11,935,169
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference
From GlobeNewswire News Releases

Performance

YTD
-7.63%
-7.63%
1 Month
-1.04%
-1.04%
3 Month
-7.18%
-7.18%
6 Month
+22.37%
+22.37%
1 Year
-0.18%
-0.18%

More News

Read More
Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
From GlobeNewswire News Releases
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
From GlobeNewswire News Releases
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference
From GlobeNewswire News Releases
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.